APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cancer Anorexia-Cachexia Syndrome Drug

Compare research editions
View pricing & licenses

Selected research

Industry Research

Cancer Anorexia-Cachexia Syndrome Drug Industry Research Report 2026

Report ID 173974180519 December 2025126 pages

Choose your research edition.

Industry ResearchCancer Anorexia-Cachexia Syndrome Drug Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Cancer Anorexia-Cachexia Syndrome Drug Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Cancer Anorexia-Cachexia Syndrome Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cancer Anorexia-Cachexia Syndrome Drug Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Cancer Anorexia-Cachexia Syndrome Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Cancer Anorexia-Cachexia Syndrome Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Cancer Anorexia-Cachexia Syndrome Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Cancer Anorexia-Cachexia Syndrome Drug is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Cancer Anorexia-Cachexia Syndrome Drug is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Cancer Anorexia-Cachexia Syndrome Drug include Novartis AG, Viking Therapeutics Inc, RaQualia Pharma Inc, PsiOxus Therapeutics Ltd, Obexia AG, Lakewood-Amedex Inc, Incyte Corp, Aphios Corp and Aeterna Zentaris Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Cancer Anorexia-Cachexia Syndrome Drug market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Cancer Anorexia-Cachexia Syndrome Drug Market by Company

Novartis AG

Viking Therapeutics Inc

RaQualia Pharma Inc

PsiOxus Therapeutics Ltd

Obexia AG

Lakewood-Amedex Inc

Incyte Corp

Aphios Corp

Aeterna Zentaris Inc

Acacia Pharma Ltd

Cancer Anorexia-Cachexia Syndrome Drug Segment by Type

NEO-1940

Foxo1-nRNA

DLN-101

C-1889

AVGN-7

Others

Cancer Anorexia-Cachexia Syndrome Drug Segment by Application

Hospital

Clinic

Others

Cancer Anorexia-Cachexia Syndrome Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cancer Anorexia-Cachexia Syndrome Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cancer Anorexia-Cachexia Syndrome Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cancer Anorexia-Cachexia Syndrome Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Cancer Anorexia-Cachexia Syndrome Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Cancer Anorexia-Cachexia Syndrome Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Cancer Anorexia-Cachexia Syndrome Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Cancer Anorexia-Cachexia Syndrome Drug Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Cancer Anorexia-Cachexia Syndrome Drug Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Manufacturers (2021-2026) Table 8. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue of Manufacturers (2021-2026) Table 9. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Cancer Anorexia-Cachexia Syndrome Drug Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Cancer Anorexia-Cachexia Syndrome Drug Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Cancer Anorexia-Cachexia Syndrome Drug, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Cancer Anorexia-Cachexia Syndrome Drug, Product Type & Application Table 14. Global Cancer Anorexia-Cachexia Syndrome Drug Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Cancer Anorexia-Cachexia Syndrome Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Novartis AG Company Information Table 19. Novartis AG Business Overview Table 20. Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio Table 22. Novartis AG Recent Developments Table 23. Viking Therapeutics Inc Company Information Table 24. Viking Therapeutics Inc Business Overview Table 25. Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio Table 27. Viking Therapeutics Inc Recent Developments Table 28. RaQualia Pharma Inc Company Information Table 29. RaQualia Pharma Inc Business Overview Table 30. RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio Table 32. RaQualia Pharma Inc Recent Developments Table 33. PsiOxus Therapeutics Ltd Company Information Table 34. PsiOxus Therapeutics Ltd Business Overview Table 35. PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio Table 37. PsiOxus Therapeutics Ltd Recent Developments Table 38. Obexia AG Company Information Table 39. Obexia AG Business Overview Table 40. Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio Table 42. Obexia AG Recent Developments Table 43. Lakewood-Amedex Inc Company Information Table 44. Lakewood-Amedex Inc Business Overview Table 45. Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio Table 47. Lakewood-Amedex Inc Recent Developments Table 48. Incyte Corp Company Information Table 49. Incyte Corp Business Overview Table 50. Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio Table 52. Incyte Corp Recent Developments Table 53. Aphios Corp Company Information Table 54. Aphios Corp Business Overview Table 55. Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio Table 57. Aphios Corp Recent Developments Table 58. Aeterna Zentaris Inc Company Information Table 59. Aeterna Zentaris Inc Business Overview Table 60. Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio Table 62. Aeterna Zentaris Inc Recent Developments Table 63. Acacia Pharma Ltd Company Information Table 64. Acacia Pharma Ltd Business Overview Table 65. Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio Table 67. Acacia Pharma Ltd Recent Developments Table 68. Global Cancer Anorexia-Cachexia Syndrome Drug Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 69. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Region (2021-2026) & (K Units) Table 70. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Region (2021-2026) Table 71. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Region (2027-2032) & (K Units) Table 72. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Region (2027-2032) Table 73. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Region (2021-2026) & (US$ Million) Table 74. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Region (2021-2026) Table 75. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Region (2027-2032) & (US$ Million) Table 76. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Region (2027-2032) Table 77. North America Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2021-2026) & (K Units) Table 79. North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2027-2032) & (K Units) Table 80. North America Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2021-2026) & (US$ Million) Table 81. North America Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2027-2032) & (US$ Million) Table 82. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2021-2026) & (K Units) Table 84. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2027-2032) & (K Units) Table 85. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2021-2026) & (US$ Million) Table 86. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2027-2032) & (US$ Million) Table 87. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2021-2026) & (K Units) Table 89. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2027-2032) & (K Units) Table 90. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2021-2026) & (US$ Million) Table 91. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2027-2032) & (US$ Million) Table 92. South America Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. South America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2021-2026) & (K Units) Table 94. South America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2027-2032) & (K Units) Table 95. South America Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2021-2026) & (US$ Million) Table 96. South America Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2027-2032) & (US$ Million) Table 97. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2021-2026) & (K Units) Table 99. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2027-2032) & (K Units) Table 100. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2021-2026) & (US$ Million) Table 101. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2027-2032) & (US$ Million) Table 102. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2021-2026) & (K Units) Table 103. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2027-2032) & (K Units) Table 104. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type (2021-2026) Table 105. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type (2027-2032) Table 106. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type (2021-2026) & (US$ Million) Table 107. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type (2027-2032) & (US$ Million) Table 108. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Type (2021-2026) Table 109. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Type (2027-2032) Table 110. Global Cancer Anorexia-Cachexia Syndrome Drug Price by Type (2021-2026) & (US$/Unit) Table 111. Global Cancer Anorexia-Cachexia Syndrome Drug Price by Type (2027-2032) & (US$/Unit) Table 112. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2021-2026) & (K Units) Table 113. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2027-2032) & (K Units) Table 114. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application (2021-2026) Table 115. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application (2027-2032) Table 116. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Application (2021-2026) & (US$ Million) Table 117. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Application (2027-2032) & (US$ Million) Table 118. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Application (2021-2026) Table 119. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Application (2027-2032) Table 120. Global Cancer Anorexia-Cachexia Syndrome Drug Price by Application (2021-2026) & (US$/Unit) Table 121. Global Cancer Anorexia-Cachexia Syndrome Drug Price by Application (2027-2032) & (US$/Unit) Table 122. Key Raw Materials Table 123. Raw Materials Key Suppliers Table 124. Cancer Anorexia-Cachexia Syndrome Drug Distributors List Table 125. Cancer Anorexia-Cachexia Syndrome Drug Customers List Table 126. Cancer Anorexia-Cachexia Syndrome Drug Industry Trends Table 127. Cancer Anorexia-Cachexia Syndrome Drug Industry Drivers Table 128. Cancer Anorexia-Cachexia Syndrome Drug Industry Restraints Table 129. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Cancer Anorexia-Cachexia Syndrome Drug Product Image Figure 5. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Cancer Anorexia-Cachexia Syndrome Drug Market Size (2021-2032) & (US$ Million) Figure 7. Global Cancer Anorexia-Cachexia Syndrome Drug Sales (2021-2032) & (K Units) Figure 8. Global Cancer Anorexia-Cachexia Syndrome Drug Average Price (US$/Unit) & (2021-2032) Figure 9. NEO-1940 Product Image Figure 10. Foxo1-nRNA Product Image Figure 11. DLN-101 Product Image Figure 12. C-1889 Product Image Figure 13. AVGN-7 Product Image Figure 14. Others Product Image Figure 15. Hospital Product Image Figure 16. Clinic Product Image Figure 17. Others Product Image Figure 18. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Share by Manufacturers in 2025 Figure 19. Global Manufacturers of Cancer Anorexia-Cachexia Syndrome Drug, Manufacturing Sites & Headquarters Figure 20. Global Top 5 and 10 Cancer Anorexia-Cachexia Syndrome Drug Players Market Share by Revenue in 2025 Figure 21. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Cancer Anorexia-Cachexia Syndrome Drug Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 23. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Region in 2025 Figure 24. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Region in 2025 Figure 25. North America Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country in 2025 Figure 26. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2021-2032) Figure 27. North America Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country (2021-2032) Figure 28. United States Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Canada Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Europe Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country in 2025 Figure 31. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2021-2032) Figure 32. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country (2021-2032) Figure 33. Germany Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. France Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. U.K. Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Italy Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Netherlands Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country in 2025 Figure 39. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2021-2032) Figure 40. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country (2021-2032) Figure 41. China Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Japan Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. South Korea Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. India Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Australia Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. China Taiwan Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Southeast Asia Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Southeast Asia Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. South America Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country in 2025 Figure 50. South America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2021-2032) Figure 51. South America Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country (2021-2032) Figure 52. Mexico Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Brazil Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Argentina Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Colombia Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country in 2025 Figure 57. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2021-2032) Figure 58. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country (2021-2032) Figure 59. Turkey Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. UAE Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type (2021-2032) Figure 63. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Type (2021-2032) Figure 64. Global Cancer Anorexia-Cachexia Syndrome Drug Price (US$/Unit) by Type (2021-2032) Figure 65. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application (2021-2032) Figure 66. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Application (2021-2032) Figure 67. Global Cancer Anorexia-Cachexia Syndrome Drug Price (US$/Unit) by Application (2021-2032) Figure 68. Cancer Anorexia-Cachexia Syndrome Drug Value Chain Figure 69. Cancer Anorexia-Cachexia Syndrome Drug Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Cancer Anorexia-Cachexia Syndrome Drug Industry Opportunities and Challenges

Scope & coverage.

Types
  • NEO-1940
  • Foxo1-nRNA
  • DLN-101
  • C-1889
  • AVGN-7
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Novartis AG
  • Viking Therapeutics Inc
  • RaQualia Pharma Inc
  • PsiOxus Therapeutics Ltd
  • Obexia AG
  • Lakewood-Amedex Inc
  • Incyte Corp
  • Aphios Corp
  • Aeterna Zentaris Inc
  • Acacia Pharma Ltd

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size (2021-2032)
  4. 2.2.2 Global Cancer Anorexia-Cachexia Syndrome Drug Sales (2021-2032)
  5. 2.2.3 Global Cancer Anorexia-Cachexia Syndrome Drug Market Average Price (2021-2032)
  6. 2.3 Cancer Anorexia-Cachexia Syndrome Drug by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 NEO-1940
  9. 2.3.3 Foxo1-nRNA
  10. 2.3.4 DLN-101
  11. 2.3.5 C-1889
  12. 2.3.6 AVGN-7
  13. 2.3.7 Others
  14. 2.4 Cancer Anorexia-Cachexia Syndrome Drug by Application
  15. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  16. 2.4.2 Hospital
  17. 2.4.3 Clinic
  18. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Cancer Anorexia-Cachexia Syndrome Drug Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Cancer Anorexia-Cachexia Syndrome Drug Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Cancer Anorexia-Cachexia Syndrome Drug Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Cancer Anorexia-Cachexia Syndrome Drug, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Cancer Anorexia-Cachexia Syndrome Drug, Product Type & Application
  8. 3.8 Global Manufacturers of Cancer Anorexia-Cachexia Syndrome Drug, Established Date
  9. 3.9 Global Cancer Anorexia-Cachexia Syndrome Drug Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Novartis AG
  2. 4.1.1 Novartis AG Company Information
  3. 4.1.2 Novartis AG Business Overview
  4. 4.1.3 Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
  6. 4.1.5 Novartis AG Recent Developments
  7. 4.2 Viking Therapeutics Inc
  8. 4.2.1 Viking Therapeutics Inc Company Information
  9. 4.2.2 Viking Therapeutics Inc Business Overview
  10. 4.2.3 Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
  12. 4.2.5 Viking Therapeutics Inc Recent Developments
  13. 4.3 RaQualia Pharma Inc
  14. 4.3.1 RaQualia Pharma Inc Company Information
  15. 4.3.2 RaQualia Pharma Inc Business Overview
  16. 4.3.3 RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
  18. 4.3.5 RaQualia Pharma Inc Recent Developments
  19. 4.4 PsiOxus Therapeutics Ltd
  20. 4.4.1 PsiOxus Therapeutics Ltd Company Information
  21. 4.4.2 PsiOxus Therapeutics Ltd Business Overview
  22. 4.4.3 PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
  24. 4.4.5 PsiOxus Therapeutics Ltd Recent Developments
  25. 4.5 Obexia AG
  26. 4.5.1 Obexia AG Company Information
  27. 4.5.2 Obexia AG Business Overview
  28. 4.5.3 Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
  30. 4.5.5 Obexia AG Recent Developments
  31. 4.6 Lakewood-Amedex Inc
  32. 4.6.1 Lakewood-Amedex Inc Company Information
  33. 4.6.2 Lakewood-Amedex Inc Business Overview
  34. 4.6.3 Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
  36. 4.6.5 Lakewood-Amedex Inc Recent Developments
  37. 4.7 Incyte Corp
  38. 4.7.1 Incyte Corp Company Information
  39. 4.7.2 Incyte Corp Business Overview
  40. 4.7.3 Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
  42. 4.7.5 Incyte Corp Recent Developments
  43. 4.8 Aphios Corp
  44. 4.8.1 Aphios Corp Company Information
  45. 4.8.2 Aphios Corp Business Overview
  46. 4.8.3 Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
  48. 4.8.5 Aphios Corp Recent Developments
  49. 4.9 Aeterna Zentaris Inc
  50. 4.9.1 Aeterna Zentaris Inc Company Information
  51. 4.9.2 Aeterna Zentaris Inc Business Overview
  52. 4.9.3 Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
  54. 4.9.5 Aeterna Zentaris Inc Recent Developments
  55. 4.10 Acacia Pharma Ltd
  56. 4.10.1 Acacia Pharma Ltd Company Information
  57. 4.10.2 Acacia Pharma Ltd Business Overview
  58. 4.10.3 Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
  60. 4.10.5 Acacia Pharma Ltd Recent Developments
5 Global Cancer Anorexia-Cachexia Syndrome Drug Market Scenario by Region
  1. 5.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Region: 2021-2032
  3. 5.2.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Region: 2021-2026
  4. 5.2.2 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Region: 2027-2032
  5. 5.3 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Region: 2021-2032
  6. 5.3.1 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Region: 2021-2026
  7. 5.3.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Region: 2027-2032
  8. 5.4 North America Cancer Anorexia-Cachexia Syndrome Drug Market Facts & Figures by Country
  9. 5.4.1 North America Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2021-2032)
  11. 5.4.3 North America Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Cancer Anorexia-Cachexia Syndrome Drug Market Facts & Figures by Country
  15. 5.5.1 Europe Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2021-2032)
  17. 5.5.3 Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Cancer Anorexia-Cachexia Syndrome Drug Market Facts & Figures by Country
  35. 5.7.1 South America Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2021-2032)
  37. 5.7.3 South America Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.7.7 Colombia
  42. 5.8 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Market Facts & Figures by Country
  43. 5.8.1 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country: 2021 VS 2025 VS 2032
  44. 5.8.2 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2021-2032)
  45. 5.8.3 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2021-2032)
  46. 5.8.4 Turkey
  47. 5.8.5 Saudi Arabia
  48. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2021-2032)
  2. 6.1.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type (2021-2032)
  4. 6.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type (2021-2032)
  5. 6.2.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Cancer Anorexia-Cachexia Syndrome Drug Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2021-2032)
  2. 7.1.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application (2021-2032)
  4. 7.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Application (2021-2032)
  5. 7.2.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Cancer Anorexia-Cachexia Syndrome Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Cancer Anorexia-Cachexia Syndrome Drug Value Chain Analysis
  2. 8.1.1 Cancer Anorexia-Cachexia Syndrome Drug Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Cancer Anorexia-Cachexia Syndrome Drug Production Mode & Process
  5. 8.2 Cancer Anorexia-Cachexia Syndrome Drug Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Cancer Anorexia-Cachexia Syndrome Drug Distributors
  8. 8.2.3 Cancer Anorexia-Cachexia Syndrome Drug Customers
9 Global Cancer Anorexia-Cachexia Syndrome Drug Analyzing Market Dynamics
  1. 9.1 Cancer Anorexia-Cachexia Syndrome Drug Industry Trends
  2. 9.2 Cancer Anorexia-Cachexia Syndrome Drug Industry Drivers
  3. 9.3 Cancer Anorexia-Cachexia Syndrome Drug Industry Opportunities and Challenges
  4. 9.4 Cancer Anorexia-Cachexia Syndrome Drug Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst